Cargando…

Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge

BACKGROUND: Elucidation of the molecular mechanisms involved in the pathogenesis of coronavirus disease 2019 (COVID-19) may help to discover therapeutic targets. METHODS: To determine the metabolomic profile of circulating plasma from COVID-19 survivors with pulmonary sequelae 3 months after dischar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Juanjuan, Zhou, Mei, Luo, Ping, Yin, Zhengrong, Wang, Sufei, Liao, Tingting, Yang, Fan, Wang, Zhen, Yang, Dan, Peng, Yi, Geng, Wei, Li, Yunyun, Zhang, Hui, Jin, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929060/ https://www.ncbi.nlm.nih.gov/pubmed/33596592 http://dx.doi.org/10.1093/cid/ciab147

Ejemplares similares

Changes in glomerular filtration rate and metabolomic differences in severely ill coronavirus disease survivors 3 months after discharge
por: Zhou, Mei, et al.
Publicado: (2022)

Comparison of Residual Pulmonary Abnormalities 3 Months After Discharge in Patients Who Recovered From COVID-19 of Different Severity
por: Zhou, Mei, et al.
Publicado: (2021)

The Correlation Between Clinical Features and Viral RNA Shedding in Outpatients With COVID-19
por: Liao, Tingting, et al.
Publicado: (2020)

Plasma Metabolomic Profiles in Recovered COVID-19 Patients without Previous Underlying Diseases 3 Months After Discharge
por: Zhang, Shujing, et al.
Publicado: (2021)

Respiratory, Cardiac, and Neuropsychiatric Manifestations of Postacute Sequelae of Coronavirus Disease 2019 in Lima, Peru
por: Rahman, Rifat S, et al.
Publicado: (2023)

Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China
por: Liu, Tingting, et al.
Publicado: (2021)

Recovering from COVID-19: psychological sequelae and post-traumatic growth six months after discharge
por: Bonazza, Federica, et al.
Publicado: (2022)

The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network
por: Zisis, Sokratis N, et al.
Publicado: (2022)

Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma
por: Bonny, Tania S, et al.
Publicado: (2020)

Estimation of Coronavirus Disease 2019 Hospitalization Costs From a Large Electronic Administrative Discharge Database, March 2020–July 2021
por: Shrestha, Sundar S, et al.
Publicado: (2021)

Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset
por: Wynberg, Elke, et al.
Publicado: (2021)

Clinical Characteristics of Pregnant Women With Coronavirus Disease 2019 in Wuhan, China
por: Cheng, Biheng, et al.
Publicado: (2020)

Gastrointestinal Sequelae 3 and 6 Months After Hospitalization for Coronavirus Disease 2019
por: Rizvi, Anam, et al.
Publicado: (2021)

Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection
por: Miyakawa, Kei, et al.
Publicado: (2021)

Spread of Coronavirus 2019 From Wuhan to Rural Villages in the Hubei Province
por: You, Maolin, et al.
Publicado: (2020)

Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge
por: Liang, Limei, et al.
Publicado: (2020)

Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia
por: DiNubile, Mark J, et al.
Publicado: (2022)

Epidemiological and Clinical Findings of Short-Term Recurrence of Severe Acute Respiratory Syndrome Coronavirus 2 Ribonucleic Acid Polymerase Chain Reaction Positivity in 1282 Discharged Coronavirus Disease 2019 Cases: A Multicenter, Retrospective, Observational Study
por: Chen, Sheng-Long, et al.
Publicado: (2020)

Pulmonary Sequelae of Coronavirus Disease 2019
por: Whiteson, Jonathan H.
Publicado: (2023)

Long COVID Symptomatology After 12 Months and Its Impact on Quality of Life According to Initial Coronavirus Disease 2019 Disease Severity
por: Fischer, Aurélie, et al.
Publicado: (2022)

Dying at Home Due to Coronavirus Disease 2019
por: Edwards, Jessie K, et al.
Publicado: (2022)

Differentiating Between 2019 Novel Coronavirus Pneumonia and Influenza Using a Nonspecific Laboratory Marker–Based Dynamic Nomogram
por: Wang, Linghang, et al.
Publicado: (2020)

Immunoregulatory Roles of Extracellular Vesicles and Associated Therapeutic Applications in Lung Cancer
por: Yin, Zhengrong, et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

Postacute Sequelae of SARS-CoV-2 Infection and Impact on Quality of Life 1–6 Months After Illness and Association With Initial Symptom Severity
por: O’Keefe, James B, et al.
Publicado: (2021)

Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China
por: Wang, Yaping, et al.
Publicado: (2020)

Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)
por: Boscolo‐Rizzo, Paolo, et al.
Publicado: (2021)

Prevalence of and Factors Associated With Post-Coronavirus Disease 2019 (COVID-19) Condition in the 12 Months After the Diagnosis of COVID-19 in Adults Followed in General Practices in Germany
por: Kostev, Karel, et al.
Publicado: (2022)

Candida auris Colonization After Discharge to a Community Setting: New York City, 2017–2019
por: Bergeron, Genevieve, et al.
Publicado: (2020)

Community-Acquired Pneumonia in Canada During Coronavirus Disease 2019
por: Mandell, Lionel A, et al.
Publicado: (2022)

Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate
por: Clancy, Cornelius J, et al.
Publicado: (2022)

Coronavirus Disease 2019 Severity and Risk of Subsequent Cardiovascular Events
por: Wiemken, Timothy L, et al.
Publicado: (2022)

Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial
por: Baksh, Sheriza N, et al.
Publicado: (2023)

A Randomized Controlled Study Assessing Convalescent Immunoglobulins vs Convalescent Plasma for Hospitalized Patients With Coronavirus 2019
por: Maor, Yasmin, et al.
Publicado: (2023)

Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019( )
por: Castanha, Priscila M S, et al.
Publicado: (2022)

Six-month follow-up of functional status in discharged patients with coronavirus disease 2019
por: Du, Hou-wei, et al.
Publicado: (2021)

Post-Acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 Infection by Viral Variant and Vaccination Status: A Multicenter Cross-Sectional Study
por: Kahlert, Christian R, et al.
Publicado: (2023)

Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings
por: Chandna, Arjun, et al.
Publicado: (2022)

Antibody and T-Cell Responses 6 Months After Coronavirus Disease 2019 Messenger RNA-1273 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant
por: Sanders, Jan-Stephan F, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o2ts7fihkn9iqjvljlbsjjnuio